• February 21, 2019
• 0

Novo Nordisk has received U.S. FDA approval for Esperoct (turoctocog alfa peg, N8-GP) for the treatment of children and adults with haemophilia A. Today's decision permits physicians to prescribe the drug for...

• February 21, 2019
• 0

Abbott and Novo Nordisk have begun a non-exclusive partnership to provide integrated digital solutions for patients with diabetes requiring insulin. The collaboration enables insulin data to be shared between Novo...